ARTICLE | Company News
Aphios, Boston University Medical Center, NIH cancer news
September 24, 2007 7:00 AM UTC
Aphios and the center received a one-year $260,000 Phase I Small Business Technology Transfer (STTR) grant from NIH's National Cancer Institute to develop APH-M109 to treat hormone-refractory prostat...